A detailed history of Wetzel Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 12,527 shares of PFE stock, worth $385,455. This represents 0.2% of its overall portfolio holdings.

Number of Shares
12,527
Previous 10,706 17.01%
Holding current value
$385,455
Previous $308,000 12.66%
% of portfolio
0.2%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $47,145 - $54,138
1,821 Added 17.01%
12,527 $347,000
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $279,747 - $363,361
10,706 New
10,706 $308,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $173B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wetzel Investment Advisors, Inc. Portfolio

Follow Wetzel Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetzel Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wetzel Investment Advisors, Inc. with notifications on news.